Best's Market Segment Report: AM Best Revises Outlook on German Non-Life Insurance Segment to Negative
AM Best is revising its outlook on Germany’s non-life insurance segment to negative from stable.
The environment in which Germany’s non-life insurers operate significantly changed in the first half of 2022 and uncertainty brings negative pressure to the segment.
AM Best’s decision to revise the outlook reflects its view that economic uncertainty and increased inflation risks will likely pressure German non-life insurer’s growth prospects and profitability over the next year. Rising inflation and supply chain disruptions is leading to increasing claims inflation in property and industrial lines, while motor is further affected by a rise in vehicle usage compared with the COVID-19 period. Together, these factors put pressure on underwriting margins for the segment. AM Best believes that German insurers will continue to aim for overall pricing discipline in their quest to maintain underwriting profitability, although competitive pressure in an environment of rising claims inflation will make it more difficult.
However, the new Best’s Market Segment Report, “Market Segment Outlook:
To access a complimentary copy of this market segment report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=325665.
AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in
Copyright © 2022 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.
src="https://cts.businesswire.com/ct/CT?id=bwnewssty=20221104005100r1sid=acqr8distro=nxlang=en" style="width:0;height:0" />
View source version on businesswire.com: https://www.businesswire.com/news/home/20221104005100/en/
Senior Financial Analyst
+31 20 308 5431
konstantin.langowski@ambest.com
Director,
+44 20 7397 0322
richard.banks@ambest.com
Senior Director, Analytics
Head of Operations
+31 20 308 5421
angela.yeo@ambest.com
Director,
+44 20 7397 0280
edem.kuenyehia@ambest.com
Source: AM Best


SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Allstate Corporation – ALL
Phoenix Seniors Have Most Medicare Drug Plan Choice Reports AAMSI
Advisor News
- A rising retirement challenge: The license to spend
- Financial stress leaves less room for retirement saving
- Giving while you’re living: 3 frequently asked questions about gifting
- Helping clients prepare for one of their biggest retirement expenses
- Important year-end financial conversations every advisor must have
More Advisor NewsAnnuity News
- A rising retirement challenge: The license to spend
- What lower interest rates mean to annuity payouts
- AM Best downgrades A-Cap insurers amid financial and regulatory troubles
- Lawsuit claims Delaware Life hid billions in insurer-linked investments
- AM Best to Deliver Presentation at 2026 ACLI Annual Conference
More Annuity NewsHealth/Employee Benefits News
Life Insurance News